RenovoRx, Inc. Human Resources Contracts & Agreements
25 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Change of Control Agreements (5)
- Compensation Agreements (6)
- Consulting Agreements (8)
- Change in Control and Severance Agreement, dated June 6, 2024, by and between the Company and Ronald B. Kocak (Filed With SEC on June 7, 2024)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on April 1, 2024)
- Outside Director Compensation Policy (Filed With SEC on November 13, 2023)
- Form of Amendment to Change of Control and Severance Agreement, dated June 1, 2023 (Filed With SEC on August 16, 2023)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 31, 2023)
- Outside Director Compensation Policy (Filed With SEC on November 14, 2022)
- Change in Control and Severance Agreement by and between RenovoRx, Inc. and Angela Gill Nelms, dated August 17, 2022 (Filed With SEC on September 19, 2022)
- Consulting Agreement by and between RenovoRx, Inc. and Danforth Advisors, LLC, dated April 25, 2022 (Filed With SEC on July 19, 2022)
- Amendment to Consulting Agreement, by and between RenovoRx, Inc. and Ramtin Agah, M.D., dated January 25, 2022 (Filed With SEC on March 30, 2022)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 30, 2022)
- Amended and Restated 2021 Omnibus Equity Incentive Plan and Forms of Stock Option Grant Notice and Option Agreement (Filed With SEC on March 30, 2022)
- Key Service Provider Incentive Compensation Plan (Filed With SEC on November 15, 2021)
- Change in Control and Severance Agreement, by and between RenovoRx, Inc. and Ramtin Agah, effective as of November 11, 2021 (Filed With SEC on November 15, 2021)
- Change in Control and Severance Agreement, by and between RenovoRx, Inc. and Shaun Bagai, effective as of November 11, 2021 (Filed With SEC on November 15, 2021)
- Amendment to Consulting Agreement, by and between RenovoRx, Inc. and Ramtin Agah, MD, dated November 11, 2021 (Filed With SEC on November 15, 2021)
- Consulting Agreement, by and between RenovoRx, Inc. and Ramtin Agah, MD, dated January 1, 2018 (Replaces incorrect exhibit previously filed.) (Filed With SEC on November 15, 2021)
- Outside Director Compensation Policy (Filed With SEC on November 15, 2021)
- 2021 Omnibus Equity Incentive Plan and Forms of Stock Option Grant Notice and Option Agreement (Filed With SEC on November 15, 2021)
- Form of 2021 Equity Incentive Plan (Filed With SEC on August 5, 2021)
- Form of 2021 Equity Incentive Plan (Filed With SEC on July 21, 2021)
- Amended Consulting Agreement with Paul Manners (Filed With SEC on July 21, 2021)
- Consulting Agreement with Paul Manners (Filed With SEC on July 21, 2021)
- Amended Consulting Agreement with Ramtin Agah, MD (Filed With SEC on July 21, 2021)
- Consulting Agreement with Ramtin Agah, MD (Filed With SEC on July 21, 2021)
- 2013 Stock Incentive Plan (Filed With SEC on July 21, 2021)
